Status: current, Not sufficiently defined by necessary conditions definition status. Date: 18-Jan 2023. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2505021000001118 | Landiolol | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 2505041000001111 | Landiolol (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Landiolol | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier | ||
| Landiolol | Is a | Product containing beta-1 adrenergic receptor antagonist | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Landiolol 300mg powder for solution for infusion vials | Is a | True | Landiolol | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR